Synmosa Biopharma Corp (4114):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Synmosa Biopharma Corp (4114) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8053
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Synmosa Biopharma Corp (Synmosa) is a pharmaceutical company that manufactures, markets and distributes generic medicines. The company produces non-pharmaceutical products such as cosmeceutical and nutrition products, and food supplements in effervescent tablet and granule forms. It offers products in the therapeutic areas of cardiovascular, respiratory, urology, sex hormone, gynecology and cancer treatment. Synmosa also provides contract manufacturing services. The company offers its products in various dosage forms such as nasal sprays, solids, semi-solids and liquids. It markets its products through a distribution network to medical centers, regional hospitals, district hospitals, clinics and drug stores. The company has partners in Finland, France, Japan, Australia, Thailand, Singapore, and others. Synmosa is headquartered in Taipei, Taiwan.

Synmosa Biopharma Corp (4114) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Innopharmax Raises Funds in Venture Financing 10
Licensing Agreements 11
Tibet Hemony Pharma Enters into Licensing Agreement with Synmosa Biopharma 11
Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 12
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 13
Equity Offering 14
Innopharmax to Raise up to USD5.2 Million in Public Offering 14
Synmosa Biopharma Raises USD2 Million in Public Offering of Shares 15
Synmosa Biopharma Raises USD15 Million in Rights Offering of Shares 16
Innopharmax Raises USD8 Million in Rights Offering of Shares 17
Innopharmax Completes IPO 18
Acquisition 19
Synmosa Biopharma Plans to Acquire Remaining Stake in Pharmaceutical Company for USD4.2 Million 19
Synmosa and InnoPharmax Acquire Minority Stake in Seven Star Pharma 20
Innopharmax to Acquire 16% Stake in Pharma Company 21
Synmosa Biopharma Acquires Ningbo Youhe Commercial Pharma 22
Synmosa Biopharma To Acquire Majority Stake In Pharma Company 23
Synmosa Biopharma Corp – Key Competitors 24
Synmosa Biopharma Corp – Key Employees 25
Synmosa Biopharma Corp – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synmosa Biopharma Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Innopharmax Raises Funds in Venture Financing 10
Tibet Hemony Pharma Enters into Licensing Agreement with Synmosa Biopharma 11
Synmosa Biopharma Enters into Licensing Agreement with Kyorin Pharma 12
InnoPharma Enters Into Licensing Agreement With Fresenius Kabi For Acetylcysteine Solution 13
Innopharmax to Raise up to USD5.2 Million in Public Offering 14
Synmosa Biopharma Raises USD2 Million in Public Offering of Shares 15
Synmosa Biopharma Raises USD15 Million in Rights Offering of Shares 16
Innopharmax Raises USD8 Million in Rights Offering of Shares 17
Innopharmax Completes IPO 18
Synmosa Biopharma Plans to Acquire Remaining Stake in Pharmaceutical Company for USD4.2 Million 19
Synmosa and InnoPharmax Acquire Minority Stake in Seven Star Pharma 20
Innopharmax to Acquire 16% Stake in Pharma Company 21
Synmosa Biopharma Acquires Ningbo Youhe Commercial Pharma 22
Synmosa Biopharma To Acquire Majority Stake In Pharma Company 23
Synmosa Biopharma Corp, Key Competitors 24
Synmosa Biopharma Corp, Key Employees 25
Synmosa Biopharma Corp, Subsidiaries 26

List of Figures
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Synmosa Biopharma Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Synmosa Biopharma Corp (4114):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Del Taco Holdings, Inc.:戦略・SWOT・企業財務分析
    Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Del Taco Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Lakeland Bancorp, Inc.:企業の戦略・SWOT・財務情報
    Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Maruha Nichiro Corporation
    Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report Summary Maruha Nichiro Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Team Energy Corporation:企業の戦略的SWOT分析
    Team Energy Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Commonwealth Scientific and Industrial Research Organisation-製薬・医療分野:企業M&A・提携分析
    Summary Commonwealth Scientific and Industrial Research Organisation (CSIRO) is a national science agency that conducts research in climate adaptation, bio-security, renewable and energy, farming and food production, and information technology, and mining and manufacturing services, and others. The …
  • New Standard Energy Ltd (NSE):企業の財務・戦略的SWOT分析
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Grupo Aeromexico SAB de CV:企業の財務・戦略的SWOT分析
    Grupo Aeromexico SAB de CV - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hikma Pharmaceuticals Plc (HIK):企業の財務・戦略的SWOT分析
    Hikma Pharmaceuticals Plc (HIK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Harvard Stem Cell Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Stem Cell Institute (HSCI) a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core …
  • Sunland Group Ltd:企業の戦略・SWOT・財務情報
    Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Sunland Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • NanoRepro AG (NN6):医療機器:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • FirstEnergy Corp:発電所・企業SWOT分析
    FirstEnergy Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Respira Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Respira Therapeutics Inc (Respira) is a pharmaceutical development company that develops dry powder inhaler technologies. The company develops Inhaler technologies to enable targeted lung delivery of drugs to treat pulmonary diseases. It develops products used for the treatment of pulmonary …
  • Hansen Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Oxford Biodynamics Plc:医療機器:M&Aディール及び事業提携情報
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a developer of biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, inflammatory, cardiovascular and neu …
  • Shin-Etsu Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Westinghouse Electric Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Westinghouse Electric Company, LLC (Westinghouse), a subsidiary of Toshiba Corporation, is a nuclear energy company. It offers nuclear plant products, technologies, nuclear fuel, plant design and related services to utilities across the world. The company conducts the development, licensing, …
  • ZAP (ZAAP):企業の財務・戦略的SWOT分析
    ZAP (ZAAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potent …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆